CD19 Protein – Human CD19 recombinant protein

Reference:
Product nameCD19 Protein - Human CD19 recombinant protein
Uniprot IDP15391
Uniprot linkhttp://www.uniprot.org/uniprot/P15391
Origin speciesHomo sapiens (Human)
Expression systemEukaryotic expression
SequenceMPPPRLLFFLLFLTPMEVRPEEPLVVKVEEGDNAVLQCLKGTSDGPTQQLTWSRESPLKPFLKLSLGLPGLGIHMRPLAIWLFIFNVSQQMGGFYLCQPGPPSEKAWQPGWTVNVEGSGELFRWNVSDLGGLGCGLKNRSSEGPSSPSGKLMSPKLYVWAKDRPEIWEGEPPCLPPRDSLNQSLSQDLTMAPGSTLWLSCGVPPDSVSRGPLSWTHVHPKGPKSLLSLELKDDRPARDMWVMETGLLLPRATAQDAGKYYCHRGNLTMSFHLEITARPVLWHWLLRTGGWKENLYFQGSHHHHHH
Molecular weight34.12kDa
Protein delivered with Tag?Yes
Purity estimated80%
Buffer150 mM NaCl, 50 mM Tris-HCl, pH 7.5
FormLyophilized
Delivery conditionDry Ice
Delivery lead time in business days5-7
Storage condition4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
BrandProteoGenix
Host speciesMammalian cells
ApplicationsELISA,WB
Fragment TypePartial
Aliases /SynonymsB-lymphocyte antigen CD19, CD19
ReferencePX-P4004
NoteFor research use only

Description of CD19 Protein - Human CD19 recombinant protein

General Information on CD19 protein

CD19 protein also known as B-lymphocyte antigen CD19, T-cell Surface Antigen LEU-12 and CDID3 is a type I transmembrane protein coded by the gene CD19 in humans. The protein consists of a single transmembrane domain with a cytoplasmic C-terminus and an extracellular N-terminus. CD19 protein is expressed in B cell lineage but not expressed in plasma cells. This protein is also present in follicular dendritic cells. As such CD19 protein can be used a biomarker for B lymphocyte development and follicular dendritic cells. CD19 protein plays a critical role in maintaining the balance between humoral, antigen-induced response and tolerance induction.
CD19 protein acts as coreceptor for the B-cell antigen receptor complex (BCR) and functions as an adaptor protein for the recruitment of cytoplasmic signals. It decreases the threshold for activation of downstream signaling pathways involved in B-cell responses to antigens. CD protein activates signaling pathways responsible fot the activation of phosphatidylinositol 3-kinase. The latter is responsible for the mobilization of intracellular Ca2+ stores. CD19 protein is not required for early steps of B cell differentiation in the blood marrow. However, CD19 protein is required for normal B-Cell differentiation and B-cell proliferation in response to antigen challenges. This protein is also needed in the production of normal levels of high-affinity antibodies and for normal levels of serum immunoglobulins.
CD19 protein interacts with several proteins and protein complexes such as CD81 and CR2/CD21. The direct interaction of CD protein with CD81 (via the second extracellular domain) is essential for the trafficking and compartmentalization of CD19 receptor on the cell surface of activated B cells. CD19 protein, along with CR2/CD21, CD81 and IFITM1/CD225, is part of a complex in the membrane of mature B-cells. Other CD19 protein interactions include GRB2 and SOS (when phosphorylated on Tyr-348 and/or Tyr-378), PLCG2 (when phosphorylated on Tyr-409), LYN and the regulatory p85 subunit of phosphatidylinositol 3-kinase.

SDS-PAGE For CD19 Protein - Human CD19 recombinant protein

CD19 Protein - Human CD19 recombinant protein, on SDS-PAGE under non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “CD19 Protein – Human CD19 recombinant protein”

Your email address will not be published. Required fields are marked *

Related products

Blinatumomab Biosimilar – Anti-CD19, CD3E mAb – Research Grade
Biosimilar

Blinatumomab Biosimilar – Anti-CD19, CD3E mAb – Research Grade

PX-TA1067 400€
Taplitumomab Biosimilar – Anti-CD19  mAb – Research Grade
Biosimilar

Taplitumomab Biosimilar – Anti-CD19 mAb – Research Grade

PX-TA1201 400€
Mogamulizumab Biosimilar – Anti-CCR4, CD194 mAb – Research Grade
Biosimilar

Mogamulizumab Biosimilar – Anti-CCR4, CD194 mAb – Research Grade

PX-TA1258 400€
Coltuximab Biosimilar – Anti-CD19  mAb – Research Grade
Biosimilar

Coltuximab Biosimilar – Anti-CD19 mAb – Research Grade

PX-TA1345 400€
Denintuzumab Biosimilar – Anti-CD19 mAb – Research Grade
Biosimilar

Denintuzumab Biosimilar – Anti-CD19 mAb – Research Grade

PX-TA1348 400€
Obexelimab Biosimilar – Anti-CD19 mAb – Research Grade
Biosimilar

Obexelimab Biosimilar – Anti-CD19 mAb – Research Grade

PX-TA1363 400€
Tafasitamab Biosimilar – Anti-CD19 mAb – Research Grade
Biosimilar

Tafasitamab Biosimilar – Anti-CD19 mAb – Research Grade

PX-TA1365 400€
Inebilizumab Biosimilar – Anti-CD19 mAb – Research Grade
Biosimilar

Inebilizumab Biosimilar – Anti-CD19 mAb – Research Grade

PX-TA1385 400€
Plozalizumab Biosimilar – Anti-CCR2, CD192 mAb – Research Grade
Biosimilar

Plozalizumab Biosimilar – Anti-CCR2, CD192 mAb – Research Grade

PX-TA1395 400€
Duvortuxizumab Biosimilar – Anti-CD19, CD3E mAb – Research Grade
Biosimilar

Duvortuxizumab Biosimilar – Anti-CD19, CD3E mAb – Research Grade

PX-TA1432 400€
Loncastuximab Biosimilar – Anti-CD19  mAb – Research Grade
Biosimilar

Loncastuximab Biosimilar – Anti-CD19 mAb – Research Grade

PX-TA1481 400€
Leronlimab Biosimilar – Anti-CCR5, CD195 mAb – Research Grade
Biosimilar

Leronlimab Biosimilar – Anti-CCR5, CD195 mAb – Research Grade

PX-TA1511 400€
Ensomafusp Biosimilar – Anti-CD19 mAb – Research Grade
Biosimilar

Ensomafusp Biosimilar – Anti-CD19 mAb – Research Grade

PX-TA1834 400€
MDX-1342 Biosimilar – Anti-CD19 mAb – Research Grade
Biosimilar

MDX-1342 Biosimilar – Anti-CD19 mAb – Research Grade

PX-TA1928 400€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products